A Health Optimizer Therapy, or HOT, is a pharmaceutical used not merely to treat or prevent disease, but to continuously improve and maintain optimal health in people who are not acutely sick. The term marks a fundamental shift in how we think about what medicine is for.

Up until now, medicine has operated primarily in damage-control mode. You reach for aspirin when you have a headache, antibiotics when you have an infection, chemotherapy when you have cancer. Even preventative medicine like vaccines, statins, or blood pressure drugs are organized around avoiding disaster. The entire system is built around the concept of illness, defined as deviation from a baseline called normal.

The purpose of HOTs is not to restore you to normal, but to optimize you beyond it. If we compare to nutrition, for most of human history, "healthy eating" meant not starving. In the 20th century, we developed a far richer understanding of nutrition and we began supplementing our diets to fine-tune our health according to our individual needs.

HOTs are the pharmaceutical equivalent of that nutritional revolution. They target fundamental biological systems like energy regulation, muscle metabolism, appetite signaling, and aging pathways in order to help those systems function better than they naturally would under modern conditions.

The first generation of HOTs is GLP-1 receptor agonist drugs like semaglutide (Ozempic/Wegovy) and tirzepatide (Zepbound/Mounjaro). These were originally developed for type 2 diabetes, but their effects extend far beyond blood sugar control. They reduce fat, preserve cardiovascular health, moderate addictive behaviors, improve sleep, and more. Their broad optimization potential is what earns them the HOT designation. Future HOTs will target bone health, immune resilience, cognitive function, skin health, and other systems.

Explore the evidence...

• Medicine is undergoing a paradigm shift from reactive crisis management to proactive health optimization. Just as nutrition evolved from simply preventing starvation to a sophisticated, personalized practice of supplementing and fine-tuning health, medicine is now beginning the same transition.
   
  • GLP-1 drugs were originally approved for type 2 diabetes, but their benefits now extend across at least eleven organs, tissues, and body systems including cardiovascular health, addiction, sleep, joints, and mental health. Learn more about the full scope of HOT health benefits in our Rethinking Health report.
  
  
  Image source: Corley et al., 2025 – preprint still under review.
  
  
  
  • The shift from illness-treatment to health optimization is not merely philosophical. It has direct implications for every major sector of the economy, from healthcare and food to agriculture, insurance, and criminal justice. Learn more about the implications for various industries in our Rethinking Health report.

• The first HOTs (GLP-1 drugs) already represent one of the fastest-adopted class of pharmaceuticals in history, with semaglutide and tirzepatide each generating over $30 billion in annual global revenues as of early 2026. 
  • Learn more about the HOTs disruption trajectory in our Rethinking Health report.
  • Read about how AI is accelerating the development of next-generation HOTs in our Rethinking Health report.

• HOTs are classified by RethinkX as an Architectural Big Bang Disruption — a technology that arrives with superior capability at lower cost than existing alternatives, with implications that cascade across multiple industries simultaneously. This classification implies rapid adoption that incumbents cannot easily resist.
  • Learn more about the Seba Technology Disruption Framework
  • See how the STDF applies to the HOTs disruption
    
    

Witness the transformation

We are entering a new era of healthcare based on a categorically different kind of medicine whose purpose is not just to save us from illness, but to help us be the best version of ourselves.

The next generation of HOTs will trigger a multi-trillion-dollar global disruption, affecting dozens of industries across multiple sectors, driving a radical global improvement in health and wellness encompassing at least 1 billion people worldwide before 2040.

Optimizing well with advanced HOTs will soon become as important as eating well with nutritious foods. Nations, industries, and individuals that recognize this early and act decisively will be best positioned to capture the extraordinary benefits of this transformation.

Learn more about the HOT disruption and its implications for health, society, and the economy.

Disclaimer

The information provided in this FAQ is for general informational and educational purposes only and is not intended to constitute medical advice, diagnosis, or treatment. This content does not establish a doctor-patient relationship. The content regarding GLP-1 receptor agonists (or any other medical treatments) should not be used as a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment options. Never disregard professional medical advice or delay in seeking it because of something you have read here. The authors and publishers of this FAQ and related report make no representation or warranty, express or implied, regarding the accuracy, adequacy, validity, reliability, availability, or completeness of any information presented. Reliance on any information provided here is solely at your own risk.